reported Gui-zhi-Fu-ling Wan treatment reduced inflammatory markers such as hs-CRP, IL-6, and TNF-α and improved PCOS-IR by remodeling the relative abundance of multiple intestinal flora (237). Here, IL6 is linked to polycystic ovary syndrome.